Closing Remarks | Artificial Intelligence: The Future of Medicine & Health Care Is Here @StanfordHospital

Stanford Health Care | Closing Remarks | Artificial Intelligence: The Future of Medicine & Health Care Is Here @StanfordHospital | Uploaded September 2024 | Updated October 2024, 38 minutes ago.
Speaker:
Rick Shumway, MHA, President & CEO, Stanford Health Care Tri-Valley and Stanford Medicine Partners

In closing. Rick Shumway, the President and CEO of Stanford Health Care Tri-Valley and Stanford Medicine Partners, emphasizes the importance of continued conversation in driving progress in the health care industry in the realm of AI and technology. He expresses optimism about having Stanford Medicine experts, including those at the event, leading the effort and devoting time to explore AI’s potential in medicine and health care responsibly.

Hosted in Dublin, CA, Artificial Intelligence: The Future of Medicine & Health Care Is Here brought together Stanford Medicine experts and the Tri-Valley community, for a live discussion on the transformative effects of AI on medicine and health care, with examples of how Stanford Medicine is using AI responsibly for the benefit of the Tri-Valley community and beyond.

The Truth About Dietary Supplements: Evidence-Based Insights

Diagnosing Prostate Cancer: Moving Beyond PSAs, Gleason Scores and Biopsies Through Advanced Imaging

Hypertrophic Cardiomyopathy (HCM) Comprehensive Treatment & Care

Transforming Cardiac Rehabilitation Symposium (Part 3/6)

Deep Brain Stimulation (DBS) for Parkinson’s Disease, Essential Tremor, and Epilepsy

$Osteoporosis: Prevention and Treatment Osteoporosis is a condition in which bones lose mass and become weak and brittle. It affects 10 million people and causes two million fractures in the U.S. per year. Joy Wu, MD, Chief, Division of Endocrinology, discusses the testing, diagnosing, and treatment of osteoporosis. She describes the condition’s risk factors, who should get a bone density test (DXA), and what steps you can take to decrease your risk. Dr. Wu covers common medications such as Fosamax (Alendronate), Boniva (Ibandronate) and other osteoporosis medications, including the pros and cons of each. Finally, Dr. Wu answers many questions from the audience. Joy Wu, MD, PhD, is a board-certified endocrinologist who specializes in treating osteoporosis and other bone and mineral diseases. Dr. Wu is Chief of the Division of Endocrinology, Gerontology and Metabolism and Vice Chair of Basic Science in the Department of Medicine at Stanford. Want to know more? Ask a Librarian. Our medical librarians are here to help you find reliable information to answer your health-related questions. We use a variety of the most current, scientifically based resources to answer your specific questions and will send you a research packet tailored to you. This is a free service open to everyone. https://healthlibrary.stanford.edu/research-services.html Take 5 minutes for yourself. Check out Stanford Health Librarys free mindfulness and meditation resources including guided meditations to help ease pain, aid in healthful sleep, promote successful surgery, and more: https://healthlibrary.stanford.edu/books-resources/mindfulness-meditation.html$

The facts about kidney living donation | Thaderines inspiring story

Nutrition Pitfalls to Avoid for Lasting Change

Type 2 Diabetes and Obesity - Explained in Under 10 Minutes

Black Women and Genetic Risk of Breast Cancer